These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29285866)

  • 21. Clinical decision making: from theory to practice. What do we do about costs?
    Eddy DM
    JAMA; 1990 Sep; 264(9):1161, 1165, 1169-70. PubMed ID: 2117076
    [No Abstract]   [Full Text] [Related]  

  • 22. Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction.
    Hadley J; Mitchell JM; Sulmasy DP; Bloche MG
    Health Serv Res; 1999 Apr; 34(1 Pt 2):307-21. PubMed ID: 10199677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
    Datta A; Dave D
    Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year evolution of drug prescribing in a university adult intensive care unit.
    Carron C; Voirol P; Eggimann P; Pannatier A; Chioléro R; Wasserfallen JB
    Appl Health Econ Health Policy; 2012 Sep; 10(5):355-8. PubMed ID: 22809277
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the effects of drug price reduction policies on older people in Taiwan.
    Chu HL; Liu SZ; Romeis JC
    Health Serv Manage Res; 2011 Feb; 24(1):1-7. PubMed ID: 21285360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Introducing Mixed Payment Systems for Physicians: Experimental Evidence.
    Brosig-Koch J; Hennig-Schmidt H; Kairies-Schwarz N; Wiesen D
    Health Econ; 2017 Feb; 26(2):243-262. PubMed ID: 26708170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe.
    Schutte T; Tichelaar J; Nanayakkara P; Richir M; van Agtmael M
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):278-283. PubMed ID: 27639184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorting into payment schemes and medical treatment: A laboratory experiment.
    Brosig-Koch J; Kairies-Schwarz N; Kokot J
    Health Econ; 2017 Dec; 26 Suppl 3():52-65. PubMed ID: 29285865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economist's model of physician behavior.
    Reinhardt UE
    JAMA; 1999 Feb; 281(5):462-5. PubMed ID: 9952209
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing overuse in healthcare: advancing Choosing Wisely.
    Born K; Kool T; Levinson W
    BMJ; 2019 Nov; 367():l6317. PubMed ID: 31690578
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
    Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
    Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The medical trade.
    Bawaskar HS
    Indian J Med Ethics; 2013; 10(4):278. PubMed ID: 24152357
    [No Abstract]   [Full Text] [Related]  

  • 34. Study Of Physician And Patient Communication Identifies Missed Opportunities To Help Reduce Patients' Out-Of-Pocket Spending.
    Ubel PA; Zhang CJ; Hesson A; Davis JK; Kirby C; Barnett J; Hunter WG
    Health Aff (Millwood); 2016 Apr; 35(4):654-61. PubMed ID: 27044966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmaceutical expenditure among primary care physicians in the province of Cuenca (Spain)].
    Segura Benito MJ; Moya Martínez P; Escribano Sotos F
    Gac Sanit; 2010; 24(5):391-6. PubMed ID: 20444527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity?
    DiStefano MJ; Levin JS
    AMA J Ethics; 2019 Aug; 21(8):E679-685. PubMed ID: 31397663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating physician performance in oncology: moneyball becomes impactball.
    Fisch MJ; Abbruzzese JL; Hong WK
    J Oncol Pract; 2014 Jan; 10(1):79-81. PubMed ID: 24443736
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulatory theory: commercially sustainable markets rely upon satisfying the public interest in obtaining credible goods.
    Warren-Jones A
    Health Econ Policy Law; 2017 Oct; 12(4):471-493. PubMed ID: 28414003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the impact of budget controls on the prescribing behaviours of physicians treating dialysis-dependent patients.
    Chang RE; Tsai YH; Myrtle RC
    Health Policy Plan; 2015 Nov; 30(9):1142-51. PubMed ID: 25355070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to optimize the prescription of laboratory tests? Success and failures in an academic hospital.
    Fillée C; Beguin C; Habimana L; Hubert C; Philippe M
    Scand J Clin Lab Invest; 2018 May; 78(3):197-203. PubMed ID: 29382230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.